Gazyva (obinutuzumab)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Gazyva (obinutuzumab), covering 2016-11-04 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]